Antagonism of Neostigmine in Continuous Infusion of Mivacurium
NCT07524959
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Neuromuscular Blocking Agents
Interventions
DRUG:
Neostigmine
Sponsor
Beijing Tongren Hospital